Biopharma Dealmakers
Last updated ISSN 2730-6275
Biopharma Dealmakers is published by Springer Nature in medicine. It is a subscription journal. Its article processing charge is not published.
Is your paper a fit?
The surest way to know is to compare your own abstract against what this journal has actually been publishing, rather than against its aims-and-scope page. Paste your abstract and Journal Hunt will tell you how close Biopharma Dealmakers is — and show you journals like it.
What it publishes
Recent work in Biopharma Dealmakers concentrates on these topics, taken from its published record rather than from its own description:
- Biotechnology and Related Fields
- Science, Research, and Medicine
- Biomedical Ethics and Regulation
- Pharmaceutical Economics and Policy
- Biosimilars and Bioanalytical Methods
- Monoclonal and Polyclonal Antibodies Research
- Biomedical and Engineering Education
- Legal case studies and regulations
- Computational Drug Discovery Methods
- Health Systems, Economic Evaluations, Quality of Life
Key facts
| Publisher | Springer Nature |
|---|---|
| ISSN | 2730-6275, 2730-6283 |
| Subject area | Medicine |
| Access | Subscription |
| Article processing charge | Not published |
| Indexed in | Not recorded |
| Articles published | 200 |
| Publishing since | 2015 |
| Journal website | www.nature.com/biopharmdeal/ |
Facts come from OpenAlex, DOAJ and Wikidata and may lag the journal’s own pages. Check the publisher’s site before submitting. Indexing shown here is what is recorded, not a complete picture — about a third of journals have no indexing recorded anywhere we can read, so “not recorded” does not mean a journal is absent from Scopus or Web of Science.
Journals like Biopharma Dealmakers
Other established journals in medicine, if this one is not the right home for your paper: